Publication

Abstract : The Non-Alcoholic Fatty Liver Disease (NAFLD) has emerged as the leading type of chronic liver disease worldwide. Non-Alcoholic Fatty Liver Disease is dened as there is evidence of hepatic steatosis, either by imaging or histology and there are no causes of secondary hepatic accumulations such as signicant alcohol consumption, use of steato-genic medication or hereditary disorders. In India, NAFLD is emerging as an important cause of liver disease. Epidemiological studies suggest the prevalence of NAFLD to be around 9 – 32 % in general Indian population, with a higher incidence amongst overweight or obese and diabetic / pre-diabetic patients. Ayurveda also vividly described Liver Diseases in the context of Yakrit Roga in different classical texts. Palasa Kshara Bhavitha Pippali Churna is mentioned in Chakradattam in Pliha Yakrit Adhikaram. Indications are Gulma Plihapaham, Yakrit Vriddhi Prasamanam, Agni Deepanam and Rasayanam. The present study aims to evaluate the general potential of oral administration of Palasa Kshara Bhavitha Pippali Churna for the clinical outcome of NAFLD. Assessment on USG, LFT, RFT, Lipid prole and BMI was done on the 1st and 22nd day of the study. The results were statistically analysed